Trials / Sponsors / Chengdu Baiyu Pharmaceutical Co., Ltd.
Chengdu Baiyu Pharmaceutical Co., Ltd.
Industry · 3 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | A Phase Ib/II Study of BY101298 , an Oral DNA-PK Inhibitor, Combined with Radiotherapy in Patients with Malign Solid Tumor, Adult | Phase 1 / Phase 2 | 2024-05-15 |
| Recruiting | A Phase l Study of By101921, an Oral PARP7 Inhibitor, in Patients With Advanced Solid Tumors Solid Tumor, Adult | Phase 1 | 2024-03-11 |
| Active Not Recruiting | A Phase l Study of By101298, an Oral DNA-PK Inhibitor, in Patients With Advanced Solid Tumors Solid Tumor, Adult | Phase 1 | 2023-04-25 |